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Psychomotor stimulants increase dopamine levels in the striatum and promote locomotion;
however, their effects on striatal pathway function in vivo remain unclear. One model that has
been proposed to account for these motor effects suggests that stimulants drive hyperactivity
via activation and inhibition of direct and indirect pathway striatal neurons, respectively.
Although this hypothesis is consistent with the cellular actions of dopamine receptors and
received support from optogenetic and chemogenetic studies, it has been rarely tested with
in vivo recordings. Here, we test this model and observe that cocaine increases the activity of
both pathways in the striatum of awake mice. These changes are linked to a dopaminedependent cocaine-induced strengthening of upstream orbitofrontal cortex (OFC) inputs to
the dorsomedial striatum (DMS) in vivo. Finally, depressing OFC-DMS pathway with a high
frequency stimulation protocol in awake mice over-powers the cocaine-induced potentiation
of OFC-DMS pathway and attenuates the expression of locomotor sensitization, directly
linking OFC-DMS potentiation to cocaine-induced hyperactivity.
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xposure to psychomotor stimulants induces a plethora of
neurobehavioral effects that range from hyperactivity, cognitive impairments, sensitization, and tolerance, which can
eventually lead to substance abuse1. However, despite being one
of the most widely reported effects of cocaine and amphetamine,
it is not clear why stimulants cause hyperactivity. Psychostimulants increase dopamine levels in striatal regions2, which is theorized to increase and decrease the activity of direct (dMSNs) and
indirect (iMSNs) medium spiny neurons, via actions on dopamine 1 (D1R)-like and D2-like receptors3–5, respectively. Optogenetic6–8, chemogenetic9–11, synaptic inhibition12 and in vivo
calcium-activity13–15 studies support a model by which bidirectional modulation of these striatal pathways controls behavioral
responses to psychostimulants. Moreover, recent work indicates
that lateral inhibition between dMSNs and iMSNs plays a pivotal
role in determining the locomotor effects of cocaine16,17, which is
consistent with the idea that opposing activation in each pathway
underlies cocaine-induced hyperactivity. While this model links
cellular actions of cocaine to dopamine receptor function, there
have been surprisingly few direct tests of the hypothesis that
cocaine excites direct pathway neurons and inhibits indirect
pathway neurons in awake animals.
Studies that utilized immediate early genes (IEGs) as a proxy
for neural activity report that phospho-Erk, MSK1, and phosphohistone H3 were activated selectively in direct pathway neurons,
while other IEGs such as c-Fos and zif268 were activated in both
pathways18. Another study reported that cocaine enhanced c-Fos
expression in direct pathway neurons but had no observable effect
in indirect pathway neurons19. However, IEGs are expressed at
low basal levels in striatum so this approach is not ideal for
testing whether cocaine also inhibits indirect pathway neurons
in vivo. To our knowledge, only one study has included cell-type
speciﬁc calcium recordings of the dorsal striatum of awake mice,
and reported that, on average, cocaine inhibited both pathways20.
Here, we expand on this point using population calcium
recording of each pathway during exposure to cocaine and found
that, in contrast to the previously calcium imaging result but
consistent with reported IEG activation, cocaine increased the
frequency of calcium events in both populations.
To explain why both pathways would have heightened activity,
we hypothesized that cocaine may strengthen excitatory inputs to
the striatum. Dopamine, psychostimulants and other drugs of
abuse can modulate synaptic transmission from cortical
inputs21,22, and this can control striatal activity23. The OFC
projection to the striatum is a particularly important input for
multiple effects of stimulants. Hyperlocomotion and sensitization24, place preference25, cue-induced reinstatement26,27, compulsive behavior28 and cognitive dysfunctions29,30 have been
linked to abnormalities in orbitofrontal cortex (OFC)-striatal
circuits following cocaine exposure and withdrawal or dopamine
neuron self-stimulation. Ex vivo studies have also linked a
potentiation of OFC inputs onto dorsomedial striatum (DMS)
neurons to some of these behavioral maladaptations24,28. Therefore, we developed a model for examining OFC-DMS connectivity in vivo in awake mice to test our hypothesis that cocaine
potentiates OFC-DMS inputs. Brieﬂy, we expressed an excitatory
opsin in the OFC and implanted recording wires in the downstream DMS. We delivered short “test pulses” to the OFC and
measured the resulting evoked LFPs in the DMS as animals were
exposed to cocaine and other stimulants. Using this model, we
found that cocaine causes a dopamine-dependent potentiation of
OFC-DMS inputs. Two other stimulants recapitulated this
increase in OFC-DMS connectivity, which was blocked by pretreatment with dopaminergic antagonists. Further, the enhanced
OFC-DMS pathway function was associated with an increased
OFC-evoked ﬁring in striatal neurons, indicating a concomitant
2

increase of OFC input efﬁcacy. Together, our results support our
hypothesis, demonstrating that psychostimulants potentiate OFC
light-evoked responses in the DMS, which enhance OFC control
over DMS output.
To test the necessity of OFC-DMS potentiation for cocaineinduced hyperactivity, we asked whether we could de-potentiate
OFC-DMS inputs to counteract the increased striatal neural
activity, and thus attenuate cocaine-induced hyperlocomotion.
Cortico-striatal pathway stimulation can alleviate behavioral
symptoms of neurological and psychiatric disorders31, including
drug-related behavior in rodents32–34 and humans35. In particular, clinical and pre-clinical36 results show that highfrequency deep brain stimulation (DBS) of different ventral
striatum sub-regions attenuates drug-seeking behavior37. In
addition, 1 Hz and 12 Hz optogenetic or electrical stimulation of
prefrontal cortex (PFC) inputs induce long-term depression
(LTD) in nucleus accumbens (NAc) slices and attenuate
cocaine-seeking behavior32 and locomotor sensitization in
rodents33,34, respectively. Cortical inputs onto DMS can also
undergo plasticity: while low-frequency38 and high-frequency
stimulation39 promote LTD, theta-burst stimulation (TBS)40
induces long-term potentiation (LTP) ex vivo. Importantly, lowfrequency stimulation of OFC inputs combined with a D1Rantagonist induces LTD in dorsal striatum brain slices, and
attenuates behavioral perseveration in compulsive mice28.
However, all prior work on this topic was done in the ex vivo
slice preparation, and the effects of stimulation protocols on
OFC-DMS circuit function of awake animals have not been
examined. To address this, we tested the ability of multiple
plasticity protocols to modify the strength of the OFC-DMS
projection, in awake mice, while monitoring evoked responses in
this circuit in real-time. We identiﬁed a high-frequency stimulation protocol that robustly depressed the OFC-DMS evoked
responses, and found that this same protocol also attenuated the
cocaine-induced OFC-DMS potentiation and the hyperlocomotor actions of cocaine in vivo. Altogether, these data
suggest that cocaine facilitates OFC-DMS synapses, increasing
both direct and indirect pathway activity in the striatum of
awake mice, and thereby driving cocaine-induced hyperactivity.
Results
Cocaine exposure increases neuronal activity in dorsomedial
striatum in vivo. To investigate the effects of cocaine on striatal
circuits, animals received an intraperitoneal (i.p.) injection of
cocaine (20 mg/Kg) or saline (cSAL) as control. Cocaine strongly
increased locomotor activity (Fig. 1a) and the expression of
phospho c-Fos, a marker of neuronal activation in the striatum
(Fig. 1b, c). More speciﬁcally, cocaine signiﬁcantly increased
average c-Fos expression in the dorsomedial portion of the
striatum (DMS) compared to saline, with non-signiﬁcant
increases in dorsolateral (DLS) and ventral striatum (VS;
Fig. 1c). To investigate whether the increased c-Fos expression
was associated with an increased neuronal ﬁring, we implanted
32-channel arrays in DMS for in vivo electrophysiology recordings. Animals were placed in an open-ﬁeld and neuronal activity
was recorded for 30 minutes before and after an i.p. injection of
either saline (cSAL, n = 7 mice) or cocaine (n = 14 mice, Fig. 1d).
We recorded a total of 112 and 174 multi-units from saline and
cocaine exposed animals, respectively. Ten minutes post injection,
cocaine increased both the ﬁring rate (Fig. 1e) and the number of
modulated units (Fig. 1f and Supplementary Fig. 1a) compared to
saline. In addition, cocaine increased gamma power in DMS
(Supplementary Fig. 1b, c), which has been linked to BOLD
signals in humans41. Altogether, these data demonstrate that
cocaine increases neuronal activity in the DMS.
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Fig. 1 Cocaine increases neuronal activity in dorsomedial striatum. a Norm. velocity for saline (cSAL) and cocaine (RM two-way ANOVA; time main
effect: F(59,1121) = 2.765, p < 0.0001; drug main effect: F(1,19) = 3.829, p = 0.0652; time Χ drug interaction: F(59,1121) = 3.044, p < 0.0001). b Experimental
paradigm and heat-map of c-fos expression after i.p. saline or cocaine injections. c Averaged per-mouse phospho-c-fos positive nuclei in dorsolateral
(DLS), dorsomedial (DMS) and ventral striatum (VS; RM two-way ANOVA; region main effect: F(2,12) = 13.84, p = 0.0008; drug main effect: F(1,6) = 13.18,
p = 0.0110; region Χ drug interaction: F(2,12) = 9.789, p = 0.0030; followed by between-subject post-hoc False Discovery Rate method of Benjamini,
Krieger and Yekuteli test for saline vs cocaine; DLS t(18) = 0.7046; DMS t(18) = 5.712; VS t(18) = 0.9339). d Schematics of brain implants and experimental
time-course. e Time-course of normalized multi-unit activity (RM two-way ANOVA; time main effect: F(3.063,869.8) = 3.118, p = 0.0246; drug main effect:
F(1,284) = 6.076, p = 0.0143, time Χ drug interaction: F(59,16756) = 4.180, p < 0.0001) and binned analysis of normalized multi-unit activity (RM two-way
ANOVA; time main effect: F(1,284) = 3.732, p = 0.0544; drug main effect: F(1,284) = 6.511, p = 0.0112; time Χ drug interaction: F(1,284) = 9.185, p = 0.0027,
followed by between-subject Bonferroni post hoc test cSAL vs COC; 11–30: t(568) = 0.3359, p > 0.9999; 41–60: t(568.0) = 3.947). Insets at top: example rate
histograms showing multi-units that increased and decreased ﬁring after cocaine. f Pie-charts of non-modulated, potentiated or depressed multi-units after
saline or cocaine i.p. injections. Data are represented as single points and/or as mean ± SEM (standard error of the mean). N and n indicate number of mice
and multi-units, respectively.

Cocaine exposure increases calcium population activity in both
direct and indirect pathway. Interestingly, a population of multiunits in our recordings was inhibited by cocaine (Fig. 1f and
Supplementary Fig. 1a), suggesting that cocaine exerts bidirectional actions on different groups of neurons. To investigate
whether the bidirectional changes in multi-unit ﬁring corresponded to a, respectively, increased and decreased activity of
direct and indirect pathway, we analysed the expression of
phospho-c-Fos in dMSNs or iMSNs, differentiated by genetic
expression of a ﬂuorescent label. A by-mouse analysis revealed
that cocaine increased c-fos expression in both dMSNs (n = 4
mice) and iMSNs (n = 4 mice; Fig. 2a, b). To follow up on this
with a real-time assessment of how cocaine modulates direct and
indirect pathway, D1Cre (n = 8) and A2aCre (n = 6) mice were
transduced with a Cre-dependent DIO-GCaMP6s virus (Fig. 2c),
while WT (n = 8) mice were transduced with a virus expressing
eYFP. Mice were implanted with an optic ﬁber in the DMS to
record bulk calcium signal from each pathway in this region
(Fig. 2d). We used the eYFP animals to characterize potential

movement artifacts in our recordings and found that 7/8 eYFP
animals did not exhibit any local maxima in the ﬂuorescence
signal that exceeded 5% dF/F (Supplementary Fig. 2a). We
therefore used this as a cut-off for potential movement artifacts
and limited our analyses of calcium transients to those that were
above 5% dF/F (Supplementary Fig. 2b). D1Cre and A2aCre mice
had similar frequencies of calcium transients during pre-cocaine
period (Supplementary Fig. 2b) and comparable hyper-locomotor
responses to cocaine (Supplementary Fig. 2c). Surprisingly,
cocaine increased population transient frequency in both direct
(Fig. 2e, f) and indirect pathway (Fig. 2g, h) compared to saline
controls. All mice (n = 6 iMSN, n = 8 dMSN mice) increased
velocity with cocaine, and 12/14 mice had an increase in calcium
transient frequency after cocaine. However, these two factors did
not themselves correlate, demonstrating that the increase in calcium frequency was not solely attributable to the increase in
velocity (Supplementary Fig. 2d). Together, our c-Fos and in vivo
photometry data indicate that cocaine increases calcium activity
in direct and indirect striatal pathway neurons of the DMS.
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Fig. 2 Cocaine increases population activity of both direct and indirect pathway in DMS. a Representative images of phospho-c-fos staining: D1-tmt (D1tomato; red) and phospho-c-fos (green). Image area is a 200 µm square of tissue. b Averaged per-mouse (n = 4 mice per condition) c-fos expression after
i.p. saline (cSAL) or cocaine injections in dMSNs and iMSNs (RM two-way ANOVA; cell-type main effect: F(1,6) = 3.998, p = 0.0925; drug main effect:
F(1,6) = 14.53, p = 0.0088; cell-type Χ drug interaction: F(1,6) = 4.634, p = 0.0748; followed by between-subject post hoc False Discovery Rate method of
Benjamini, Krieger and Yekuteli test saline vs cocaine; dMSNs: t(12) = 4.370; iMSN: t(12) = 2.488). c Representative images of GCaMP6s expression in DMS
(V ventricle, AC anterior commissure, Cx cortex). Scale bar: 1 mm. d Experimental and brain schematics of ﬁber photometry experiments with example
photometry traces. Scale bar: 30 ms, 5% dF/F. e Norm. frequency of direct pathway calcium events (RM two-way ANOVA by both factors; time main
effect: F(59,413) = 1.063, p = 0.3585; drug main effect: F(1,7) = 20.37, p = 0.0028; time Χ drug interaction: F(59,413) = 2.891, p < 0.0001). f Binned norm.
frequency (RM two-way ANOVA by both factors; time main effect: F(1,7) = 0.9040, p = 0.3734; drug main effect: F(1,7) = 53.77, p = 0.0002, time Χ drug
interaction: F(1,7) = 72.32, p < 0.0001, followed by between-subject Bonferroni post-hoc test Saline vs Cocaine; 11–30: t(7) = 1.539, p = 0.3354; 31–60: t(7)
= 8.137). g Norm. frequency of indirect pathway calcium events (RM two-way ANOVA by both factors; time main effect: F(59,295) = 1.118, p = 0.2729; drug
main effect: F(1,5) = 21.45, p = 0.0057; time Χ drug interaction: F(59,295) = 2.5, p < 0.0001). h Binned frequency (RM two-way ANOVA by both factors; time
main effect: F(1,5) = 9.215, p = 0.0289; drug main effect: F(1,5) = 13.48, p = 0.0144; time Χ drug interaction: F(1,5) = 25.37, p = 0.0040; followed by
between-subject Bonferroni post-hoc test Saline vs Cocaine; 11–30: t(5) = 0.9309, p = 0.7893; 31–60: t(5) = 4.583). Data are represented as single points
and/or as mean ± SEM. N indicates number of mice.

Cocaine exposure potentiates OFC-DMS inputs. It is difﬁcult to
reconcile the cocaine-mediated increase in indirect pathway
activity with the inhibitory actions of D2R activation on iMSN
function18,21,42,43. To account for why indirect pathway neurons
were more active when the mouse was exposed to cocaine, we
hypothesized that cocaine may increase glutamatergic drive onto
both iMSNs and dMSNs. Speciﬁcally, we hypothesized that
cocaine may potentiate OFC-DMS pathway, either by enhancing
synaptic connections28 or promoting “up-states” in striatal neurons23. We ﬁrst investigated whether OFC neurons preferentially
4

innervate either direct or indirect striatal neurons. To test this, we
expressed ChR2 in the OFC of D1-tomato (D1-tmt) mice44 and
patched D1tmt-positive or D1tmt-negative neurons in the DMS
to identify dMSNs and putative iMSNs. We tested each patched
neuron for connectivity and measured the amplitude of the
evoked current. Similar to previous reports24,28, we found that the
OFC projects to both dMSNs and iMSNs, with no observed differences in connectivity rate or strength (Fig. 3a–c).
To test whether cocaine potentiated OFC-DMS inputs in vivo,
we expressed the blue light-activated opsin Chronos45 in the OFC
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Fig. 3 Cocaine increases OFC-DMS pathway efﬁcacy. a Schematic of ex vivo recordings. ChR2-eYFP was targeted to the OFC and slice recordings were
performed in the DMS of D1-tmt mice. b Example histology showing ﬂuorescence in OFC and ﬁbers in DMS. Scale bar: 1 mm. c Connectivity rates between
OFC and dMSNs or putative iMSNs. Right: example currents evoked by 4 ms illumination with blue light. Scale bar: 10 ms, 20 pA. d Representative images
of Chronos expression in OFC with ﬁbers projecting to DMS. e Time-course of normalized OFCe LFP amplitude for cocaine and saline (cSAL) (two-way
ANOVA; time main effect: F(59,27720) = 13.18, p < 0.0001; drug main effect: F(1,27720) = 225.7, p < 0.0001; time Χ drug interaction: F(59, 27720) = 10.27, p <
0.0001). Scale bar: 20 ms, 2 μV. f Binned OFCe LFP amplitude (two-way ANOVA; time main effect: F(1,924) = 35.11, p < 0.0001; drug main effect: F(1,924) =
14.27, p = 0.0002, time Χ drug interaction: F(1,924) = 14.27, p = 0.0002; followed by between-subject Bonferroni post hoc test; Pre: cSAL vs cocaine: t(924)
= 0, p > 0.9999; post: t(924) = 5.342). g Pie-charts reporting the number of signiﬁcantly potentiated, depressed or non-signiﬁcantly modulated OFCe LFP
responses. h Representative raster-plot and peri-stimulation histogram of OFCe responses. i Time-course of normalized OFC-stimulation evoked ﬁring rate
(RM one-way ANOVA, F(59,2183) = 3.056). j Binned OFCe ﬁring frequency in response to cocaine (two-tailed Wilcoxon matched pairs signed rank test: W
= 392.0). k Pie-charts reporting the number of OFCe ﬁring responses. Data are represented as single points and/or as mean ± SEM. N, n indicate number
of mice and OFCe LFPs or units included in the analysis.

(Fig. 3d) and measured light-evoked changes in striatal local ﬁeld
potentials (LFPs), a measure of cortical-input efﬁcacy46,47 before
(Pre) and after (Post) mice received an i.p. injection of cocaine or
saline (Cocaine, n = 14 mice, and cSAL, n = 7 mice, Fig. 3d). We
included wires with evoked LFP responses for further analysis
(see Methods). This included 312 wires for cocaine, and 152 wires
for saline. As we hypothesized, cocaine increased the amplitude of
OFC-evoked (OFCe) striatal LFP responses (Fig. 3e–g). This
effect was also observed at a per-mouse level, when OFCe LFP
responses from each mouse were averaged (Supplementary
Fig. 3a). Next, to investigate whether changes in evoked LFPs
were associated with alterations in neuronal ﬁring, we examined

whether cocaine also potentiated OFCe spiking in the striatum.
Thirty-eight of 197 (22%) recorded striatal multi-units were
activated by OFC stimulation, consistent with a glutamatergic
input from OFC (Supplementary Fig. 3b–d). Similar to the effect
we observed on OFCe LFPs, cocaine also potentiated OFCe
spiking in these units (Fig. 3h–k). Thus, we conclude that cocaine
increases the synaptic efﬁcacy of OFC inputs onto striatal
neurons, which may be the source of enhanced spiking in both
pathways during cocaine exposure.
Cocaine-mediated OFC-DMS potentiation is dopaminedependent. To investigate whether OFC-DMS potentiation was
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dependent on dopamine, we ﬁrst tested whether this potentiation
occurred with other psychostimulants. Mice that were implanted
with 32-channel arrays in DMS were i.p. injected with damphetamine (d-amph, n = 8 mice) or saline as controls (dSAL,
n = 8 mice). We observed that at the dose of 3 mg/Kg, damphetamine increased locomotor activity (Fig. 4a), OFCe LFP
amplitudes (Fig. 4b, c), and the number of potentiated LFPs
(Fig. 4d) compared to saline. As with cocaine, a between-subject
analysis against saline revealed that d-amph increased averaged
responses per mouse as well (Supplementary Fig. 4a). Considering that cocaine and amphetamine both have multiple mechanisms of action48, we sought to selectively isolate the contribution
of dopamine to the potentiation of OFC-DMS connection
strength. To do this, we assessed whether an i.p. injection of a
selective dopamine transporter (DAT) blocker49, GBR13069,
recapitulated the effects induced by cocaine and amphetamine.
Although not as robust as cocaine and amphetamine, GBR13069
(n = 9 mice) signiﬁcantly increased both locomotor activity
(Supplementary Fig. 4b) and OFCe LFP responses (Fig. 4e–h)
6

compared to saline controls (gSAL, n = 9 mice). Finally, we
blocked dopamine receptors to test the necessity of dopamine for
potentiating OFC-DMS connection. Mice received either an i.p.
injection of a mixture of antagonists for D1R (SCH23390; 0.15
mg/Kg) and D2R (sulpiride; 25 mg/Kg; Fig. 5a), named anti-DA
(n = 5 mice), or vehicle as control (n = 5 mice). Anti-DA injection caused a slight depression in OFCe LFP amplitude when
normalized to baseline (Fig. 5a), indicating that physiological
dopamine receptor activation controls OFC-DMS pathway input
strength under basal conditions. Compared to vehicle, pretreatment with anti-DA also blunted both the cocaine-induced
hyperlocomotion (Supplementary Fig. 4c) and the increase of
OFCe LFP amplitude (Fig. 5a–c), even when normalizing for the
anti-DA mediated reduction in OFCe LFPs (Fig. 5d). Finally, we
injected these mice with cocaine after pre-treating them with
either vehicle or a mixture of a lower dose of SCH23390 (0.03 mg/
Kg) and the same dose of sulpiride (25 mg/Kg), named “low antiDA”. Analysing the same wires as with the higher dose, we found
that reducing the dose of D1R antagonist was permissive for
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OFCe LFP potentiation (Supplementary Fig. 4d), as no differences were detected compared to vehicle. Thus, we conclude that
psychostimulant-induced increase in OFC-DMS input strength
depends on dopamine and can be blocked by a D1-antagonist in a
dose-dependent manner in awake mice.
Optogenetic-mediated high-frequency stimulation depresses
OFC-DMS pathway and locomotion. As cocaine potentiated
OFC-DMS inputs, we asked whether targeted, plasticity-inducing
stimulation protocols could depress this input and block cocaineinduced behaviour, building on similar approaches used by other
groups32,34,35,50. We tested the effect of multiple stimulation
protocols in vivo, based on those that have been shown to induce
plasticity ex vivo (Fig. 6a). To monitor circuit plasticity as it
occurs in vivo, we investigated the consequences of low-frequency
(LFS: 5 Hz for 15 min; n = 7 mice for noLFS and n = 7 mice for
LFS) and theta-burst (TBS: 10 repetitions of 40 stimulations
organized in trains of 50 Hz every 10.5 Hz; n = 8 mice for noTBS
and n = 13 mice for TBS) stimulation of OFC on the amplitude of
OFCe LFP responses in DMS. Surprisingly, both LFS and TBS
failed to induce an observable plasticity in our awake preparation
(Fig. 6b–e). Next, we sought to explore the effects of HFS at OFCDMS inputs, which induces LTD at cortico-striatal inputs in slice
preparations39 and anesthetized animals51. Because of constraints
related to Chronos-induced spike ﬁdelity45, we limited our stimulation to 60 Hz. Moreover, to understand whether HFS had
any short-/long-term or additive effects52, we delivered two 5-min
60 Hz periods (ON) interleaved by a 14-min pause (interHFS)
and followed by an OFF period (post HFS). Compared to noHFS
control, HFS strongly depressed OFCe LFP responses (during
the inter-HFS phase, Fig. 6f–h), which lasted through the postHFS with no further depression. The HFS-mediated OFC-DMS
pathway depression was also observed by comparing permouse averaged responses from noHFS (n = 7 mice) and HFS
(n = 7 mice; Supplementary Fig. 5a) groups. Thus, protocols that
induce plasticity in ex vivo preparations may not induce the same
effects in vivo; and HFS can reliably depress OFC-DMS inputs in
awake animals.
Recently, it has been shown that reduced excitability of orbitostriatal inputs between co-activated neuronal ensembles

attenuates cocaine-induced psychomotor responses24. To understand whether opposite changes in orbito-striatal neuronal and
input function bidirectionally modulate locomotion, we monitored animal’s velocity during and after Chronos-mediated
optogenetic HFS of OFC, in absence of psychostimulants. During
the ﬁrst ON period (60 Hz stimulation for 5 min), we observed a
dramatic increase in mouse speed (Supplementary Fig. 5b, c),
conﬁrming an association between heightened OFC-DMS pathway activity and hyperlocomotion. This result is also consistent
with the OFC-DMS potentiation we observed with psychostimulants. In contrast, velocity decreased immediately after HFS, while
it remained unaltered at the same time-point in the control group
(Supplementary Fig. 5d). Thus, these data suggest that strengthening or weakening the OFC-DMS pathway might exert a
bidirectional control over locomotion, even in the absence of
cocaine.
HFS of OFC-DMS blocks cocaine-induced potentiation and
hyperlocomotion. As cocaine potentiated the OFC-DMS connection and HFS depressed it, we asked whether the HFS protocol
could block cocaine-induced increases in OFC-DMS connectivity,
and associated increases in DMS activity. When we tested the
effects of HFS applied to the OFC immediately after the cocaine
injection (n = 7 mice), we observed that HFS overpowered the
effect of cocaine and again depressed the OFCe LFP amplitude at
post-HFS (Fig. 7a–c). Interestingly, in the no HFS group (n = 9
mice) we replicated our earlier experiments showing that cocaine
increased the OFCe LFP amplitude (Fig. 7a–c). Again, this effect
was also apparent at a per-mouse level when comparing no HFS
vs HFS mice treated with cocaine (Supplementary Fig. 6a). HFS
also blocked the cocaine-mediated increase in the average ﬁring
rate of striatal units (Fig. 7d), conﬁrming a causal link between
the cocaine-mediated potentiation of the OFC-DMS pathway and
increases in neuronal activity in the striatum.
Finally, we examined the consequences of attenuating corticostriatal drive on the sensitization of psychomotor responses to
cocaine. For 5 consecutive days, mice bilaterally expressing either
ChR2 or eYFP in the OFC and implanted with optic ﬁbers in
DMS (Fig. 7e) received i.p. injections of cocaine (20 mg/Kg)
immediately followed by HFS. Consistent with our recording
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experiments, at the ﬁrst cocaine exposure (Coc1), HFS of OFC
inputs attenuated hyperactivity in ChR2- but not eYFPexpressing mice (Supplementary Fig. 6b). Although individual
ChR2-expressing neurons likely cannot faithfully follow a 60 Hz
stimulation train, we conﬁrmed that ChR2-mediated stimulation
increased power in the LFP at 60 Hz, conﬁrming that the DMS
population activity was modulated at that frequency (Supplementary Fig. 6c). Attenuation of locomotor responses was also
observed over the next four consecutive cocaine injections
(Fig. 7f). To test whether HFS at OFC-DMS was masking the
expression of cocaine sensitization, these same animals received a
cocaine challenge injection (without HFS) after 10 days of
withdrawal from cocaine. Without HFS, ChR2- and eYFPexpressing mice displayed similar locomotor responses to this
cocaine challenge (Fig. 7g). Thus, we conclude that HFS at OFCDMS pathway acutely interfered with the expression of
psychomotor responses to cocaine but did not prevent the
acquisition of cocaine sensitization.
Discussion
In the present study, exposure to cocaine increased the activity of
both direct and indirect pathways in DMS. We linked these
changes to a dopamine-dependent OFC input strengthening and
a greater efﬁcacy in driving the activity of DMS neurons. We

tested several optogenetic stimulation protocols and found that
high-frequency stimulation depressed OFC-DMS connectivity
and reduced locomotion. HFS also over-powered the cocaineinduced OFC-DMS potentiation and, when applied at OFCterminals, attenuated cocaine-induced hyperactivity in vivo.
Here, cocaine signiﬁcantly increased the expression of c-fos in
striatal regions, particularly in direct and indirect pathway DMS
neurons, as reported by other studies17,18. Although our in vivo
electrophysiology recordings showed a generalized increase in
striatal neuron activity, they also revealed a smaller neuronal
population that decreased its activity in response to cocaine,
which might conﬁrm important cellular specializations within
striatal circuits53,54. However, this bidirectional change did not
appear to be related to the two output pathways since photometry
recordings revealed that cocaine increases the frequency of
population calcium events in both. Thus, our results diverge from
a classic model of striatal function by which psychostimulantinduced dopamine increase would respectively enhance and
attenuate dMSN and iMSN activity via dopamine receptor activation. While this theory has been supported by evidence in
ventral striatum13 and anesthetized animals14, cocaine was also
reported to decrease population activity of both pathways in
dorsal striatum20. Despite the discrepancy in the direction of
change, our result is consistent with the Barbera et al.20 study in
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failing to provide evidence for a bidirectional action of cocaine on
population activity in the direct and indirect pathways in awake
mice. These inconsistencies point at anatomical, sub-regional or
even cellular specializations in dopamine control of striatal
pathway function which might be fundamental for a better
understanding of the circuit adaptations underlying the neurobehavioral effects of psychostimulants.
In this study, we linked the increased activity of striatal pathways to a dopamine-dependent strengthening of orbito-striatal
inputs, which resulted in a greater efﬁcacy of OFC excitatory
inputs at inducing post-synaptic neuron ﬁring in awake animals.
Given the abundance of intra-striatal collaterals55,56, we also
found a small population of neurons that decreased their activity
in response to OFC stimulation. The source of this inhibition is
most likely a di-synaptic circuit composed by OFC inputs that
excite intermediate GABA neurons that inhibit the recorded ones,
which might not be directly activated by OFC. Although lateral
inhibition plays an important role in behavioural responses to
psychostimulants16, further investigation will clarify how cocaine
modulates intra-striatal OFCe inhibitory responses.
The dopamine-dependent enhancement of OFC excitatory
inputs that we observed is consistent with a previous observation
that a reinforcing intra-cranial self-stimulation protocol causes a
long-lasting increase in cortico-striatal post-synaptic potential in
anaesthetized animals57. In addition, our data link the potentiation of OFC-inputs to downstream striatal neuron ﬁring via
possible dopamine-dependent changes in post-synaptic glutamatergic signal integration in real-time21. Considering that previous evidence showed a psychostimulant-mediated increase of
glutamate in striatal regions, particularly upon sensitization58 and
re-instatement of drug seeking behaviour59, the OFC-DMS
potentiation might also be due to pre-synaptic adaptations.
Possibly, these changes in neuronal integration and pre-synaptic
glutamate release participate in the induction of the long-lasting
adaptations observed at OFC-DMS synapses in response to
repeated cocaine administration or dopamine neuron selfstimulation24,28.
While much effort focused on the PFC to NAc pathway stimulation to block drug-seeking behaviour in rodents32,33, the
orbito-striatal pathway recently received attention for its role in
compulsive seeking28,60 and locomotor sensitization to cocaine24.
In our work, we mimicked classical stimulation protocols of
cortico-striatal inputs to monitor and modulate OFC-DMS
pathway function in awake animals, both during (ON) and
after (OFF) LFS, TBS and HFS. During high-frequency stimulation, we observed an increase in animal’s velocity, indicating that
strengthening OFC-DMS pathway acutely drives locomotion.
This conclusion is corroborated by our observation of a prominent gamma-frequency oscillation in DMS, which is thought to
be a prokinetic signal61, during cocaine-induced hyperactivity.
Previous evidence that OFC-DMS inhibition attenuates cocaineinduced hyperlocomotion24 and that HFS increases axonal
activity62, while promoting glutamate release both ex vivo63,64
and in vivo65, further supports the possibility that OFC-DMS
potentiation leads to hyperactivity. However, whether OFC neurons ﬁre action potentials in high-frequency patterns during
locomotion bouts or upon cocaine exposure to enhance glutamate
release warrants further investigation.
Upon termination of OFC-DMS stimulation (OFF period),
HFS (but neither LFS nor TBS) modiﬁed orbito-striatal input
strength. Therefore, our data indicate that HFS-induced LTD
observed in both slice preparations66 and anesthetized animals51
also occurs in awake mice. Moreover, the failure of LFS or TBS to
induce plasticity might indicate that optogenetic stimulation
in vivo does not recruit the same molecular effectors as electrical
stimulation ex vivo, as also suggested by previous observations34.
10

The depression of OFC-DMS input following our HFS protocol
might be due to multiple mechanisms, including the release of
endocannabinoids that retrogradely inhibit glutamate release66,
hetero-synaptic block of glutamate release by HFS-induced
GABA release67 or long-term adaptations in the ﬁring rates of
stimulated neurons68.
High-frequency stimulation of OFC-DMS terminals decreased
animal’s velocity both acutely and over consecutive days of
cocaine exposure. In these settings, HFS restrained but did not
prevent sensitization and did not block its expression at postwithdrawal cocaine challenge, which has been demonstrated to
depend on NAc synaptic adaptations69. Our data directly link
OFC-DMS potentiation to cocaine-induced hyperlocomotion, as
well as increases in striatal neuron ﬁring; however, this study does
not address the effects of HFS on repeated saline injections, nor at
the cocaine challenge. Therefore, it might be possible that HFS at
OFC inputs onto DMS would decrease locomotor activity even in
absence of cocaine exposure, as our data on HFS of OFC suggest.
Further experimentation will be needed to evaluate this possibility. Finally, since excitatory synapse stimulation induces forms of
hetero-synaptic plasticity70 and motor cortex stimulation can also
promote LTD51 in striatal regions, the effects of HFS on other
excitatory inputs to the striatum of awake mice and the resulting
changes in behaviour also remain to be determined.
Monitoring the strength of the OFC-DMS connection in real
time, as we did here, can link plasticity in speciﬁc brain circuits in
animals to changes in connectivity observed in clinical
studies71,72. Thus, this approach may be used in multiple circuits
to prevent or rescue aberrant forms of plasticity, induced by drugs
or diseases, via DBS or trans-cranial magnetic stimulation (TMS)
protocols in both rodents and humans32,34,35.
Methods
Animals. Wildtype (WT), D1Cre (GENSAT: EY217), A2aCre (GENSAT: KG139)73
mice on a C57Bl6/j background, D1-tomato (JAX: B6.Cg-Tg(Drd1a-tdTomato)
6Calak/J), and D2-GFP mice (Tg(Drd2-EGFP)S118Gsat) mice were used: 21 animals (12 males and 9 females) for in vivo electrophysiology experiments; 22 animals
(12 males, 10 females) for ﬁber photometry, 20 animals (14 males and 6 females) for
behavioral assessment of cocaine-induced hyperlocomotion, 6 animals (3 males and
3 females) for in vitro electrophysiology, and 8 males for phospho-c-Fos experiments. The animals were housed at the NIH research animal facility in standard
vivarium cages with ad libitum food availability and 12-hour dark/light cycle. The
experiments described here were conducted during light-period (typically between 9
a.m. and 7 p.m.). All experimental procedures were approved by the National
Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of
Health Animal Care and Use Committee.
Viral infusions and optic ﬁber implantation. Viral infections of OFC and DMS
were conducted on adult male and female mice (older than 12 weeks). Anesthesia
was induced with isoﬂurane at 2–3% and maintained during the entire surgery with
isoﬂurane at 0.5–1.5%, delivered via a mouse mask mounted on a stereotaxic
apparatus (Stoelting). Ear bars and mouth holder were used to keep the mouse
head in place while the skin was shaved and disinfected with a povidone/iodine
solution. The skull was exposed and a hole of ~0.5–1 mm diameter was performed
with a microdrill. A 5 μL Hamilton syringe was connected to a 33gauge steel
injector (Plastics1) via a hydraulic system. The injector was pre-loaded with AAVs
and gently lowered into the brain at the following coordinates: OFC: AP + 2.5 mm,
ML + 1.1 mm, DV −2.5 mm; DMS: AP + 0.5 mm, ML + 1.5 mm, DV −2.8 mm
(from bregma). A total volume of 500 nl of viral solution was delivered at each
infection site with a syringe pump (Harvard apparatus) at a rate of 50 nL min−1.
The injector was left in place for 5 min after the infusion.
For in vivo electrophysiology experiments, the animals received a unilateral
infection of the OFC. After removal of injector, suture (Coated VICRYL,
polyglactin 910; Ethicon) followed by povidone/iodine were applied to close the
wound. Animals were placed back in their home-cages on a pre-heated pad at 37 °C
until complete recovery and subcutaneously injected with buprenorphine (0.05 mg
Kg−1). Animals were allowed at least 2 weeks for viral expression before electrodes
were implanted in a second surgery.
For ﬁber photometry experiments, immediately after unilateral viral infusion in
DMS, a 5 mm long ﬁber optic cannulae (200 μm, 0.39 NA, 1.25 mm) with stainless
steel ferrule (Thorlabs) was gently lowered into DMS between 0.5 and 0.3 mm
above the infusion site for GCamP6s-emitted ﬂuorescence recordings.
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For behavioral experiments with cocaine and OFC-DMS input stimulation,
mice received bilateral opsin viral infusions in the OFC. In the same surgery, two
ﬁber optic cannulae (200 μm, 0.39 NA, 1.25 mm, ceramic ferrule) were lowered
bilaterally into DMS for OFC terminal stimulation (AP + 0.5 mm, ML ± 1.5 mm,
DV −2.8 mm).
Optic ﬁbers were ﬁxed to the skull with a layer of C&B Metabond® Quick
Adhesive Cement System and the implant was fortiﬁed with acrylic dental cement.
Upon solidiﬁcation of the implant, animals were placed back in their home-cages
on a pre-heated pad at 37 °C. After full recovery, animals received a subcutaneous
injection of buprenorphine (0.05 mg Kg−1).
Array and optic ﬁber implant for in vivo electrophysiology recordings.
Implants of recording arrays for in vivo extracellular recordings and OFC stimulation typically occurred two weeks after viral infusions. In this study, we used 32channel offset micro-arrays composed of 35 μm tungsten electrodes with polished
tips and spaced by 150 μm. Uncleaved ﬁber optic cannulae (200 μm, 0.50 NA, 1.25
mm) with ceramic ferrule were purchased from Thorlabs and cut at the desired
length for OFC stimulation. After anesthesia and skull exposure, two holes were
drilled at the stereotaxic coordinates reported above. The optic ﬁber tip was lowered 0.3 mm above the infusion site with a 10° angle in the OFC, while the array
was lowered into DMS. A grounding wire was inserted into the parietal lobe and a
mini-screw was placed contro-laterally to the array to stabilize the implant. Both
the optic ﬁber and the array were ﬁxed to the skull and screw with C&B Metabond® Quick Adhesive Cement System and then cemented with dental acrylic.
After surgery, animals were transferred to a pre-heated pad until complete recovery
and subcutaneously injected with buprenorphine (0.05 mg Kg−1). Mice were
single-housed.
Fiber photometry and calcium population activity analysis. About 2–4 weeks
after surgery, mice (8 D1Cre, 6 A2aCre and 8 WT mice) of both sexes were
acclimated for 30 min day−1 at least twice to a Phenotyper box (Noldus, PT T10/N,
24 VDC – 0.6 A) with dimensions 30 cm (l) ×30 cm (w) ×34 cm (h). On the
experimental day, mice were recorded for 30 minutes, before receiving a saline or
cocaine i.p. injection (20 mg Kg−1; counterbalanced). A mating sleeve (zirconia)
connected the stainless-steel ferrule to the patch-cord (200 μm core optic ﬁber, 0.48
NA, Doric), which both transmitted excitatory blue-light (wavelength: 475 λm,
power: ~30 μW) and collected GCaMP6s-emitted photons. An optical commutator
(Doric) was used to allow for rotation of the mice without tangling. The emitted
light passed through a dichroic mirror and 505–535 nm ﬁlter (FMC4 port minicube, Doric) and then measured with a photodetector (Model 2151, Newport).
GCaMP6s signal was collected, digitized and measured with Omniplex acquisition
system (Plexon, Inc). The change in ﬂuorescence (dF) was normalized to total
ﬂuorescence (F). In fact, absolute ﬂuorescence most likely reﬂects variance in viral
expression and ﬁber micro positioning. Thus, before proceeding with further
analysis and similarly to previous approaches74, we used a custom Python scripts
run in NeuroExplorer (script available on request) to normalize the data and
correct for bleaching in one step. Our custom-made script (available upon request)
calculated a moving window of 2 min around each data point and used this as F,
sliding this window along the entire recording trace to normalize each recorded
data point and calculate a dF/F. Fluorescence events (>5% dF/F, with at least 1 slong inter-event interval) were identiﬁed and their frequency binned in 60 s time
intervals. A time-course was generated by normalizing 1-min bin frequency values
to the average of 30 bins in the pre-injection period and expressed as percentage (%
of Pre). Larger binned frequency values for pre- and post-injection periods were
obtained by averaging the 1-min long bins within 11–30 min for Pre- and 41–60
min for post-injection periods. Animal movements in the open ﬁeld were tracked
and analyzed with Noldus Ethovision software.
In vivo electrophysiology recordings. After recovery from surgery (between 7
and 10 days), mice were connected to the recording setup and acclimated to an
open ﬁeld, 34.5 cm (l) × 34.5 cm (w) × 34.5 cm (h), head-stage and cable for at least
four sessions of 30 min each on different days. On the experimental day, multi and
single-units were collected via an Omniplex neurophysiology system (Plexon Inc)
through a multiplexing head-stage (Triangle Biosystems). Spike channels were
acquired at 40 kHz with 16-bit resolution, and band-pass ﬁltered at 150 Hz to 3
kHz before spike sorting, while LFP were digitized at 1 kHz. Single and multi-units
were sorted by principal component analysis performed with Ofﬂine sorter software and MANCOVA test determined signiﬁcant clustering of single-units vs
multi-units. To be considered a single unit the spikes from that cluster must be
signiﬁcantly different (p < 0.01) from the multi-unit cluster on the same wire.
In vitro electrophysiological recordings. Mice were C57BL/6 or heterozygous
BAC transgenic mice in which tomato expression was driven by D1R (B6.Cg-Tg
(Drd1a-tdTomato)6Calak/J from Jackson Laboratories) gene regulatory elements.
AAV1-CAG-chR2-eYFP (UNC Viral Vector Core) was injected bilaterally into the
OFC (350 μL, AP: +1.9 mm, ML: ±0.3 mm, DV: −2.5 mm) of 6-week-old mice.
Following 28 days expression, coronal slices of the DMS (220 µM) were prepared
using a vibratome in cutting solution containing: 76 mM NaCl, 26 mM NaHCO3,
75 mM sucrose, 25 mM glucose, 2.5 mM KCl, 1.25 mM NaH2PO4, 7 mM MgCl2
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and 0.5 mM CaCl2. Slices were hemisected and transferred to ice cold artiﬁcial
cerebrospinal ﬂuid (ACSF) containing: 119 mM NaCl, 2.5 mM KCl, 1.3 mM
MgCl2, 1.0 mM NaH2PO4, 26.2 mM NaHCO3, 2.5 mM CaCl2, glucose 11 mM, and
continuously bubbled with 95 % O2 and 5 % CO2. Slices were submerged in 34 °C
ACSF for 30 min and allowed to recover for another 30 min at room temperature.
They were subsequently transferred to the recording chamber, superfused with 2.5
ml min^−1 ACSF at nearly physiological temperature (30–32 °C). Slices were
visualized on a Nikon 600 N microscope equipped with a 40× objective lens.
Neurons were recorded by means of whole-cell voltage-clamp at −68 mV, and
excitatory post-synaptic currents were optically-evoked by ﬂashing blue light (473
nm, 13.9–14.6 mW) through the light path of the objective, and isolated by
recording in picrotoxin (100 µM, Sigma Biosciences). Borosilicate glass pipettes
were prepared at a resistance range of 6–9 MΩ. The internal solution contained:
CsCl 130 mM, 4 mM NaCl, 5 mM creatine phosphate, 2 mM MgCl2, 2.0 mM
Na2ATP, 0.6 mM Na3GTP, 1.1 mM EGTA and 5 mM HEPES. Currents were
ampliﬁed, ﬁltered at 2 kHz and digitized at 10 kHz using Clampex 11 (pClamp,
Molecular Devices). Access resistances were monitored by a hyperpolarizing step of
−4 mV at the onset of every sweep and the experiment was discarded if the access
resistance changed by more than 20%. ChR2 was stimulated by ﬂashing 473 nm
blue light (pulse length: 4 ms) through the light path of the microscope using an
LED powered by an LED driver under computer control. Recordings were performed in aCSF, paired pulse ratios were evoked at an interval of 50 ms. Representative example traces are shown as average of 30 consecutive oEPSCs. Data were
analyzed in Clampﬁt 11.3 software (pClamp, Molecular Devices).
Pharmacological and optogenetic manipulations for in vivo electrophysiology
recordings. Animals were exposed to pharmacological agents, optogenetic stimulation or both. Mice received intraperitoneal injections of psychostimulants
(cocaine and amphetamine, and their respective controls), dopaminergic antagonists (SCH23390, Sulpiride and their respective vehicle controls) and GBR13069
(and its control). In vivo plasticity was tested via the delivery of blue-light pulses
into the OFC at different frequencies: low-frequency stimulation (LFS) consisted in
15 min-long delivery of 15 ms-long blue-light pulses at 5 Hz; theta-burst stimulation (TBS) consisted in the repeated delivery (10 times) of 10 trains of action
potentials (at theta-frequency: 10.5 Hz) organized in 4 light-pulses at 50 Hz and
HFS consisted in the delivery of 2-blocks of 5-min long 60 Hz stimulation interleaved by a 14 min interval.
Analysis of in vivo electrophysiology recordings. The ﬁring frequency of multiand single-units during pre- and post-manipulation period was calculated in 60-s
bins with Neuroexplorer software. Average ﬁring frequencies for pre- and postmanipulation periods were calculated as average of 30 bins in pre- and 30 bins in
post-manipulation periods. A paired t-test followed by Bonferroni correction (α =
0.05 n−1 of comparisons) was performed between pre- and post-manipulation
period (10–30 min bin) to determine whether the manipulation induced signiﬁcant
changes in ﬁring frequencies. To determine the direction of the change the average
ﬁring frequency during the post-manipulation was expressed as percentage of the
pre-manipulation, such that changes >100% identiﬁed an increase while changes
<100% indicated a decrease in ﬁring frequency.
For OFC-stimulation evoked (OFCe) ﬁring frequency, animals were subjected
to 15 ms long blue-light pulses at 0.2 Hz, 30 min before and 30 min after
pharmacological or optogenetic stimulation. The power of the laser was adjusted
between 8 and 30 mW to obtain reliable responses. To determine signiﬁcant
changes in neuronal activity, ﬁring frequency was analyzed 25 ms before (OFF
period) and 25 ms after the beginning of OFC illumination (ON period). A paired
t-test between trial-by-trial values of ﬁring frequency was used to determine
signiﬁcant modulation by OFC stimulation. A paired t-test followed by Bonferroni
correction between trial-by-trial (25 ms after the beginning of blue-light
stimulation) during pre- (1–30 mins) and post-manipulation (31–60 mins) periods
was used to determine signiﬁcant modulation in OFCe ﬁring rates. A time-course
of OFCe ﬁring frequency was generated by binning OFCe ﬁring (60 s) and
expressing it as percentage of the averaged OFCe ﬁring during pre-manipulation
period. Binned OFCe ﬁring rate responses were obtained by averaging 60-sec bins
for pre- and post-manipulation period.
For OFC-stimulation evoked local-ﬁeld potentials (OFCe LFPs) responses,
animals were subjected to 15 ms long blue-light delivery into OFC at 0.2 Hz, 30
minutes before (Pre) and 30 min after (Post) pharmacological or optogenetic
manipulations. The power of the laser was adjusted between 8 and 30 mW to
obtain reliable responses. OFCe LFP amplitude was measured by using a custommade Python script as the difference between the minimum and a maximum
deﬂection point within an interval of 100 ms before and after OFC stimulation. To
determine signiﬁcantly OFCe LFP responses, a trial-by-trial paired t-test on the
peak-to-peak amplitude in each trial before (100 ms) and after (100 ms) the bluelight pulse in the pre- phase was conducted. The amplitude of signiﬁcant OFCe
LFP responses was binned in 60-s bins and expressed as percentage of averaged
OFCe LFP amplitude during pre-manipulation period. Signiﬁcantly modulated
OFCe LFP responses were identiﬁed by paired t-test followed by Bonferroni
correction (α = 0.05 n−1 of comparisons). To determine the direction of the change
of OFCe LFP responses, the averaged OFCe LFP amplitude during the postmanipulation period was expressed as percentage of the averaged OFCe LFP
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amplitude in pre-manipulation period, such that changes >100% identiﬁed an
increase while changes <100% indicated a decrease OFCe LFP amplitude. Binned
OFCe LFP responses were obtained by averaging 60-s bins for pre- and postmanipulation period. Per-mouse analysis of OFCe LFPs was conducted by
averaging the change of OFCe LFPs within each animal.
Power spectra analysis was performed by applying Bartlett single-taper, on 512
frequency values from 0 to 100 Hz and a window overlap of 50. For each electrode,
the power was expressed as a percentage of total and then averaged by mouse. Permouse power spectral densities were obtained by averaging power spectral densities
for saline and cocaine injected mice. Binned power analysis was performed by
binning and averaging power spectra values per-mouse as follows: delta (0–4 Hz),
theta (4–10 Hz), beta (10–30 Hz), low-gamma (30–80 Hz) and high-gamma
(80–100 Hz).
The averaged number of multi-units, OFCe LFPs and OFC-modulated units per
mouse (together with standard deviation) included in each data-set is reported in
Supplementary Table 1.
Animal movement in the arena was tracked via Omniplex system software
Cineplex. X and Y coordinates were used to determine instant velocity (1 s). Instant
velocity was averaged and binned (60 s) and extracted via Neuroexplorer. Binned
velocity in post-manipulation period was then normalized to the averaged binned
velocity in pre-manipulation period, to generate time-course of normalized velocity
(expressed as a percentage of Pre).
Behavioral assay of sensitization to cocaine. The sensitization of psychomotor
responses to cocaine was tested in an open-ﬁeld box of 30 cm (l) × 30 cm (w) × 43
cm (h). eYFP or ChR2-expressing animals were ﬁrst habituated to the novel
environment and patch-cord for 3 consecutive days. On habituation days, animals
were acclimated to the box for 30 min before receiving an i.p. injection of saline
(without any optical stimulation). Starting from day 4, animals were acclimated to
the box for 30 min before receiving an i.p. injection of cocaine (20 mg Kg−1)
immediately followed by HFS, with a laser power of 8 mW measured at the tip of
the optic ﬁber. This protocol was repeated for 4 more consecutive days, for a total
of 5 days of cocaine + HFS. After 10 days of withdrawal, animals were acclimated
to the box for 30 min and received an i.p. injection of cocaine without any optic
stimulation. Animal’s activity (distance moved and locomotion) was tracked with
Ethovision software. Distance moved was calculated as the sum of binned distance
moved during the 14 minutes inter-HFS and 16 min post HFS. We excluded from
the analysis a ChR2-expressing animal that at day 1 showed a distance moved
higher than 3 standard deviations from the group mean.

anesthetized (Chloral Hydrate, 7%) and perfused with 4% formaline. After overnight incubation in a 30% sucrose solution, either coronal or sagittal brain slices
containing OFC and DMS were prepared. Slices were mounted on microscope
slides with a mounting media with Fluoromount-GTM, with DAPI (Invitrogen)
and imaged with a confocal microscope (Zeiss). For in vivo electrophysiology,
behavioral and ﬁber photometry experiments implant placement was assessed
via observation of implant tract or electric-lesions (performed with a 5-s long
pulse of 10 mA; Ugo Basile Lesion Making Device).
Statistical analysis. The number of animals included in this study was chosen
based on those used in similar publications. Shapiro-Wilk test was used to assess
normality of two-sample distributions. If violated, Mann–Whitney and Wilcoxon
matched-pairs signed rank tests were applied, otherwise two-sided unpaired or
paired t-tests were used. For independent multiple-sample distribution comparisons, one-way ANOVA or non-parametric Kruskal–Wallis tests were applied and
followed by between-subject Bonferroni (parametric), one-sided t-test (parametric)
or Dunn’s (non-parametric) post hoc test. For comparing two-factors multiplesample distributions, normality of sample distribution was assumed and repeatedmeasures (RM) ANOVA, two-way ANOVA or RM two-way ANOVA were
applied. When sphericity was not assumed, Geisser-Greenhouse correction was
applied. If main effects and/or interaction were signiﬁcant, between- or withinsubject Bonferroni post-hoc or Dunnett’s tests were used to determine signiﬁcant
differences across sample distributions. For the analysis of the by-mouse expression
of c-Fos we applied the post-hoc False Discovery Rate method of Benjamini,
Krieger and Yekuteli test. In all tests, statistical signiﬁcance was determined when p
< 0.05 and n.s. indicates a non-signiﬁcant difference between sample distributions
(p > 0.05). Data are expressed as mean ± SEM. GraphPad Prism 8 software was
used for graph presentation and statistical analysis. Statistical analysis is reported in
ﬁgure legends. On graphs, p refers to p-values of main effects, comparison between
two-sample distributions or post hoc tests, while # refers to p-values of two factor
interaction upon RM or regular two-way ANOVA. Animals were randomly
assigned to each experimental condition, but experimenters were not blinded to the
treatment conditions as stimulants produced obvious behavioral changes upon
injection.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.

Data availability
Drugs. Cocaine hydrochloride (20 mg Kg−1; NDC 51552-0881-1, Fagron) and damphetamine hemisulfate salt C-IIN (3 mg Kg−1; A5880, Sigma) were obtained via
NIH pharmacy and dissolved in saline (NaCl 0.9%) to perform intra-peritoneal (i.
p.) injection of 200–300 μL. (S)-(-)-Sulpiride (25 mg Kg−1; 0895, Tocris),
SCH23390 (lowSCH: 0.03 mg Kg−1; highSCH: 0.15 mg Kg−1; 0925, Tocris) and
GBR13069 dihydrochloride (20 mg Kg−1; 0420, Tocris) were diluted in a vehicle
solution of 10% DMSO in saline for i.p. injection.

The data included in this paper are provided as Source data ﬁles and available at https://
osf.io/dup4r/.

Viruses. rAAV2/Syn-Chronos-GFP (2.1 × 1012 vg mL−1), rAAVDJ/PAAV-Ef1aDIO-GCaMP6s (3.9 × 1012 vg mL−1) and rAAV2/hSyn-eYFP (3.4 × 1012 vg mL−1)
were purchased from Virus Vector Core at University of North Carolina at Chapel
Hill. AAV5.CAG.hChR2(H134R)-mCherry.WPRE.SV40 (Addgene20938M, 3.9 ×
1012 GC mL−1) was purchased from Addgene.
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Phospho-fos experiments, immunostaining, and cell counting. Mice (5 D1-tmt
and 3 D2-gfp) were sacriﬁced 2 hours after an i.p. injection of cocaine (20 mg Kg−1)
or saline (n = 4 mice each). Brains were extracted and sectioned at 40 μm on a
vibratome (Precisionary Compressotome). Tissue slices containing the striatum
were immunostained for phospho-c-Fos (Cell Signaling monoclonal antibody
#5348), with ﬂuorescent secondary antibodies (Alexa 488 for D1-tmt mice and
Alexa 555 for D2-gfp mice).
For quantiﬁcation of striatal expression area, two striatal hemispheres per
mouse were imaged on a scanning epiﬂuorescence microscope (Leica DM6B).
Phospho-c-Fos positive nuclei were identiﬁed manually in ImageJ and their X and
Y coordinates were exported, registered to a common Atlas space, and plotted as
heatmaps with MatPlotLib in Python 3.7. For colocalization with D1-tmt or D2gfp, six two-color 10× ﬁelds of view were acquired from the DMS for each mouse
on a confocal microscope (Leica microsystems). Images were quantiﬁed in ImageJ
using the CellCounter plugin, where each phospho-c-Fos positive nucleus was also
scored as positive or negative for the complementary ﬂuorophore for cell type
identiﬁcation. To quantify the relative co-localization with D1R and D2Rexpressing MSNs, confocal images were only acquired if they included multiple Fos
positive nuclei (mean = 16.2, range = 3–32 Fos positive nuclei). This approach
over-sampled Fos positive nuclei in the images from the saline group. We therefore
normalized the number of co-labeled neurons by the total Fos in the striatum of
each mouse to obtain the extrapolated total counts in Fig. 2e.

Code availability
Python codes used for the analysis of the data included in this manuscript are provided
as Supplementary Software and available at: https://osf.io/dup4r/.
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